Brian M. Olson

761 total citations
19 papers, 582 citations indexed

About

Brian M. Olson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Brian M. Olson has authored 19 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Brian M. Olson's work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Prostate Cancer Treatment and Research (6 papers). Brian M. Olson is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Prostate Cancer Treatment and Research (6 papers). Brian M. Olson collaborates with scholars based in United States. Brian M. Olson's co-authors include Douglas G. McNeel, Laura E. Johnson, Jeremy A. Sullivan, William J. Burlingham, Brian T. Rekoske, Edward J. Dunphy, Jordan T. Becker, Brett Maricque, Heath A. Smith and Thomas Frye and has published in prestigious journals such as Clinical Cancer Research, Frontiers in Immunology and Frontiers in Oncology.

In The Last Decade

Brian M. Olson

18 papers receiving 570 citations

Peers

Brian M. Olson

IMMUN

ONCOL

PRM

EPIDE

Mara Valentini Italy

Kay Palmer Canada

Emily F. Higgs United States

I Joyeux France

Miriam Echaide Spain

Miao-La Ke China

Ichwaku Rastogi United States

Iris Mimpen United States

Joanna H. Maltbaek United States

Iranzu González Spain

Mara Valentini Italy

Brian M. Olson

450 ×1.0

IMMUN

379 ×1.3

ONCOL

125 ×0.7

38 ×0.2

PRM

44 ×0.8

EPIDE

Citations per year, relative to Brian M. Olson Brian M. Olson (= 1×) peers Mara Valentini

Countries citing papers authored by Brian M. Olson

Since Specialization

Citations

This map shows the geographic impact of Brian M. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Olson more than expected).

Fields of papers citing papers by Brian M. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Olson. The network helps show where Brian M. Olson may publish in the future.

Co-authorship network of co-authors of Brian M. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Olson. A scholar is included among the top collaborators of Brian M. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Olson. Brian M. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Collings, Amelia T., Ann Nguyen, Brian M. Olson, et al.. (2025). Damage Control Surgery in the Era of Globalization of Health Care – Military and International Outcomes: A SystematicReview. Journal of Surgical Research. 306. 101–110.

Dolmatova, Elena, Nida Waheed, Brian M. Olson, Sagar A. Patel, & Anant Mandawat. (2023). The Intersection of Prostate Cancer and Hypertension: a Call to Action. Current Treatment Options in Oncology. 24(7). 892–905. 4 indexed citations

Kyriakopoulos, Christos E., Jens C. Eickhoff, Anna C. Ferrari, et al.. (2020). Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer. Clinical Cancer Research. 26(19). 5162–5171. 47 indexed citations

Olson, Brian M., Justin J. Jeffery, Leigh Ellis, et al.. (2017). Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T Cells. Cancer Immunology Research. 5(12). 1074–1085. 28 indexed citations

Olson, Brian M., Weixiong Zhong, Erik A. Ranheim, et al.. (2017). Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand‐Binding Domain (AR‐LBD). The Prostate. 77(7). 812–821. 7 indexed citations

Rekoske, Brian T., Brian M. Olson, & Douglas G. McNeel. (2016). Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses. OncoImmunology. 5(6). e1165377–e1165377. 40 indexed citations

Rekoske, Brian T., Heath A. Smith, Brian M. Olson, Brett Maricque, & Douglas G. McNeel. (2015). PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope–Modified DNA Vaccine Immunization. Cancer Immunology Research. 3(8). 946–955. 59 indexed citations

Johnson, Laura E., et al.. (2013). Preclinical and clinical development of DNA vaccines for prostate cancer. Urologic Oncology Seminars and Original Investigations. 34(4). 193–204. 29 indexed citations

Olson, Brian M. & Douglas G. McNeel. (2013). Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials. Frontiers in Oncology. 3. 109–109. 12 indexed citations

10.

Olson, Brian M., Jeremy A. Sullivan, & William J. Burlingham. (2013). Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious Tolerance. Frontiers in Immunology. 4. 315–315. 116 indexed citations

11.

Olson, Brian M., Laura E. Johnson, & Douglas G. McNeel. (2012). The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer. Cancer Immunology Immunotherapy. 62(3). 585–596. 26 indexed citations

12.

Olson, Brian M. & Douglas G. McNeel. (2011). CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells. Cancer Immunology Immunotherapy. 60(6). 781–792. 17 indexed citations

13.

Becker, Jordan T., et al.. (2010). DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer. Journal of Immunotherapy. 33(6). 639–647. 94 indexed citations

14.

Olson, Brian M., Thomas Frye, Laura E. Johnson, et al.. (2010). HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase. Cancer Immunology Immunotherapy. 59(6). 943–953. 46 indexed citations

15.

Olson, Brian M. & Douglas G. McNeel. (2009). Methods for Constructing and Evaluating Antitumor DNA Vaccines. Methods in molecular biology. 542. 210–242. 1 indexed citations

16.

Bergendahl, Veit, et al.. (2007). LRET-Based HTS of a Small-Compound Library for Inhibitors of Bacterial RNA Polymerase. Assay and Drug Development Technologies. 5(6). 759–768. 10 indexed citations

17.

Olson, Brian M. & Douglas G. McNeel. (2007). Antibody and T‐cell responses specific for the androgen receptor in patients with prostate cancer. The Prostate. 67(16). 1729–1739. 23 indexed citations

18.

Dunphy, Edward J., Laura E. Johnson, Brian M. Olson, Thomas Frye, & Douglas G. McNeel. (2006). New approaches to identification of antigenic candidates for future prostate cancer immunotherapy. 1(2). 273–284. 7 indexed citations

19.

Bergendahl, Veit, et al.. (2003). A cross-reactive polyol-responsive monoclonal antibody useful for isolation of core RNA polymerase from many bacterial species. Protein Expression and Purification. 31(1). 155–160. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact